{
  "id": "13f487f55b056674",
  "title": "BioMarin Presence in Rare Enzyme Disorders Grows With $4 . 8B Amicus Therapeutics Acquisition",
  "description": "20251219T220000Z",
  "content": "",
  "source": "medcitynews.com",
  "source_url": "https://medcitynews.com/2025/12/biomarin-amicus-therapeutics-acquisition-rare-disease-enzyme-deficiency-bmrn-fold/",
  "published_at": "20251219T220000Z",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://medcitynews.com/2025/12/biomarin-amicus-therapeutics-acquisition-rare-disease-enzyme-deficiency-bmrn-fold/",
    "url_mobile": "",
    "title": "BioMarin Presence in Rare Enzyme Disorders Grows With $4 . 8B Amicus Therapeutics Acquisition",
    "seendate": "20251219T220000Z",
    "socialimage": "https://medcitynews.com/wp-content/uploads/sites/7/2025/05/GettyImages-1897527783.jpg",
    "domain": "medcitynews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}